The Hydration Pharmaceuticals Co Ltd (ASX: HPC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

The Hydration Pharmaceuticals Co Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $1.61 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 537.99 million
Earnings per share -0.006
Dividend per share N/A
Year To Date Return -40.00%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • The Hydration Pharmaceuticals Co Ltd (ASX: HPC)
    Latest News

    Young girl wearing glasses flexes her left bicep confidently.
    Opinions

    "Bullish because everybody is bearish" – here are 8 dogs of 2022 I'm backing for the win in 2023 

    These 8 ASX microcap stocks could bounce back in 2023.

    Read more »

    A man has a big smile on his face as he pours water over his head.
    IPOs

    Hydration Pharmaceuticals (ASX:HPC) share price rockets 31% in 2 days following IPO

    Here's all you need to know about the ASX newbie.

    Read more »

    HPC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About The Hydration Pharmaceuticals Co Ltd

    The Hydration Pharmaceuticals Co. Ltd. markets and sells a range of liquid, tablet and powder healthy hydration solutions products. The company was founded on July 24, 2017 and is headquartered in Melbourne, Australia.

    HPC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    01 Sep 2026 $0.00 $0.00 0.00% 80,000 $0.00 $0.00 $0.00
    31 Aug 2026 $0.00 $0.00 0.00% 665,806 $0.00 $0.00 $0.00
    28 Aug 2026 $0.00 $0.00 0.00% 322,721 $0.00 $0.00 $0.00
    27 Aug 2026 $0.00 $0.00 0.00% 568,019 $0.00 $0.00 $0.00
    24 Aug 2026 $0.00 $0.00 0.00% 176,872 $0.00 $0.00 $0.00

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    31 Dec 2025 Adem Karafili Expiry 500,000 $2,500
    Options expired.
    31 Dec 2025 Margaret Hardin Expiry 166,667 $833
    Options expired.
    31 Dec 2025 Nicholas(Nick) Berry Expiry 6,686,844 $33,434
    Options expired.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr George Karafotias Non-Executive Director Jun 2026
    Mr Karafotias is experienced in restructuring, reinventing and implementing turnaround strategies for ASX-listed companies. His experience includes a track record with publicly-traded businesses, predominantly in senior executive positions.
    Mr Oliver Baker Chief Executive OfficerManaging Director May 2024
    Mr Baker is the CEO of Hydralyte North America, having joined the business in 2018, taking responsibility for global sales. Prior to the Company, he worked at Swisse Wellness in a number of roles across business development, marketing and general management. After the Biostime (H&H Group) acquisition of Swisse, he led the integration team in Guangzhou China, building a local Chinese team and processes. He was then appointed General Manager of Swisse North America and was responsible for the launch of the Swisse brand with an e-commerce focused strategy in the USA and Canada. Previously he has held global and national roles in sales and marketing with a focus on sports sponsorships.
    Ms Margaret Hardin Non-Executive Director Feb 2022
    Ms Hardin is a global products senior executive, with experience. She has previously scaled two consumer goods companies to generate more than US$100m in revenue, and currently advises founders on growth opportunities. Most recently, Ms Hardin was CEO of ERGObaby Carrier Inc. During her time with the group, she revived product innovation while managing an omni-channel distributor, retail and ecommerce model across over 60 countries and 19 company-owned websites. Prior to ERGObaby Carrier Inc., Ms Hardin was CFO during the early stages of US baby and accessories company Munchkin and was progressively promoted to President and COO. She grew the company to a brand leader in the juvenile industry, where she led sales, acquisitions, brand partnerships and marketing efforts. She oversaw the opening of sales operations in Canada and launched the EMEA headquarters.
    Mr Nicholas(Nick) Peter Berry Non-Executive DirectorNon-Executive Chairman May 2024
    Mr Berry brings over 19 years of experience in the Australian finance industry, in equity and debt capital markets, mergers and acquisitions and strategic planning. With a track record in raising capital and structuring and negotiating financial transactions, Nick has experience in the field. He previously served as an Executive Director at Nomura Australia and is currently a Director of PURE Asset Management Pty Ltd.
    Mr Nick Katiforis Non-Executive Director Jun 2026
    Mr Katiforis is a financial services professional with over 20 years' experience across capital markets, equities, options and FX. He has been a Director of Futurity Trading, a financial services and trading firm, since 2000 and holds ASIC financial adviser accreditation. He brings experience in client engagement, execution, capital markets distribution and regulatory compliance.
    Ms Victoria Nadalin Company Secretary Feb 2023
    -
    Victoria Nadalin Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    J P Morgan Nominees Australia Pty Limited 100,492,130 23.33%
    Dr Ida Constable 32,500,000 7.54%
    Caroline House Superannuation Fund Pty Ltd <The Caroline House S/F A/C> 29,297,309 6.80%
    Donus Australia Foundation Limited 27,500,000 6.38%
    Jaf Capital Pty Ltd 20,882,006 4.85%
    HSBC Custody Nominees (Australia) Limited 20,179,376 4.68%
    Mr Craig Graeme Chapman <Nampac Discretionary A/C> 15,000,000 3.48%
    Super Radek Pty Ltd <Super Radek Super Fund A/C> 12,316,113 2.86%
    Paul Orlin 7,732,978 1.80%
    Mr Darren Nath 5,500,779 1.28%
    Tr Nominees Pty Ltd 5,192,750 1.21%
    Bell Potter Nominees Ltd <3165421 A/C> 5,000,000 1.16%
    Oliver Baker 4,195,331 0.97%
    Hms Orange Pty Ltd <Hms Orange Unit Trust A/C> 3,261,813 0.76%
    Mrs Merryn Elizabeth Joseph 3,000,000 0.70%
    Ff Investments Nz Limited 2,901,462 0.67%
    Gowings Whale Fund Pty Ltd <Gowings Whale A/C> 2,797,992 0.65%
    Penny Dreadful Holdings Pty Ltd <Seville Super Fund A/C> 2,700,000 0.63%
    Ankara Holdings Pty Ltd <The Ankara Family A/C> 2,562,389 0.59%
    Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 2,515,925 0.58%

    Profile

    since

    Note